{"id":"https://openalex.org/W7204687439","doi":"https://doi.org/10.1016/s2152-2650(26)01083-9","title":"POSTER: ABCL-257: Neutrophil-to-Lymphocyte Ratio and SIRI Are Associated With Survival and Relapse in Diffuse Large B-Cell Lymphoma: A Single-Center Study","display_name":"POSTER: ABCL-257: Neutrophil-to-Lymphocyte Ratio and SIRI Are Associated With Survival and Relapse in Diffuse Large B-Cell Lymphoma: A Single-Center Study","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204687439","doi":"https://doi.org/10.1016/s2152-2650(26)01083-9"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)01083-9","doi":"https://doi.org/10.1016/s2152-2650(26)01083-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01083-9","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7204687439"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5148652474","display_name":"Juliana Faleschini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210167420","display_name":"Fundacion Allende","ror":"https://ror.org/01vgvj394","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210167420"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Juliana Faleschini","raw_affiliation_strings":["Sanatorio Allende, C\u00f3rdoba, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanatorio Allende, C\u00f3rdoba, Argentina","institution_ids":["https://openalex.org/I4210167420"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016167402","display_name":"Sol Jarchum","orcid":"https://orcid.org/0000-0002-9235-7941","observed_orcids":["https://orcid.org/0000-0002-9235-7941"]},"institutions":[{"id":"https://openalex.org/I4210167420","display_name":"Fundacion Allende","ror":"https://ror.org/01vgvj394","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210167420"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Sol Jarchum","raw_affiliation_strings":["Sanatorio Allende, C\u00f3rdoba, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanatorio Allende, C\u00f3rdoba, Argentina","institution_ids":["https://openalex.org/I4210167420"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103943367","display_name":"Evelyn Colombo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210167420","display_name":"Fundacion Allende","ror":"https://ror.org/01vgvj394","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210167420"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Evelyn Colombo","raw_affiliation_strings":["Sanatorio Allende, C\u00f3rdoba, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanatorio Allende, C\u00f3rdoba, Argentina","institution_ids":["https://openalex.org/I4210167420"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047053753","display_name":"Malena Rocca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210167420","display_name":"Fundacion Allende","ror":"https://ror.org/01vgvj394","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210167420"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Malena Rocca","raw_affiliation_strings":["Sanatorio Allende, C\u00f3rdoba, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanatorio Allende, C\u00f3rdoba, Argentina","institution_ids":["https://openalex.org/I4210167420"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043632370","display_name":"Gustavo D. Jarchum","orcid":"https://orcid.org/0000-0001-6253-9317","observed_orcids":["https://orcid.org/0000-0001-6253-9317"]},"institutions":[{"id":"https://openalex.org/I4210167420","display_name":"Fundacion Allende","ror":"https://ror.org/01vgvj394","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210167420"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Gustavo Jarchum","raw_affiliation_strings":["Sanatorio Allende, C\u00f3rdoba, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanatorio Allende, C\u00f3rdoba, Argentina","institution_ids":["https://openalex.org/I4210167420"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210167420"],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S302","last_page":"S302"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.03009999915957451,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neutrophil-to-lymphocyte-ratio","display_name":"neutrophil-to-lymphocyte ratio","score":0.9319999814033508},{"id":"https://openalex.org/keywords/systemic-inflammatory-response-index","display_name":"systemic inflammation response index","score":0.765999972820282},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.7329999804496765},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.9340000152587891},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8529999852180481},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.35899999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9790999889373779},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6794000267982483},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5371999740600586},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.32519999146461487},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.30090001225471497},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.29010000824928284},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.2703000009059906},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.25769999623298645},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.2433999925851822},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.23100000619888306}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)01083-9","doi":"https://doi.org/10.1016/s2152-2650(26)01083-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01083-9","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413810177","https://openalex.org/W4413777401","https://openalex.org/W4413777321","https://openalex.org/W4386270952","https://openalex.org/W4386281990","https://openalex.org/W3094380918","https://openalex.org/W7204693399","https://openalex.org/W4308705926","https://openalex.org/W7204724262","https://openalex.org/W4413810401"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-08-31T00:00:00"}